NEW YORK (GenomeWeb News) - Illumina said yesterday that it has filed a resale registration statement with the US Securities and Exchange Commission connected to the sale of $400 million worth of .625 percent convertible senior notes due 2014.
 
The notes were originally sold in February to institutional investors, and Illumina said at the time it planned to use $200 million of the proceeds to buy shares of its own stock in a private deal.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.